Zevra Therapeutics Says FDA Extends NDA Review Period For Arimoclomol

RTTNews | 511 дней спустя
Zevra Therapeutics Says FDA Extends NDA Review Period For Arimoclomol

(RTTNews) - Zevra Therapeutics, Inc. (ZVRA) announced Monday the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for arimoclomol, an investigational orally delivered, first-in-class treatment for Niemann-Pick disease type C (NPC).

In addition, the FDA has set a new Prescription Drug User Fee Act (PDUFA) action date of September 21, 2024, and has re-affirmed its intent to present the resubmission for discussion at an advisory committee meeting to be scheduled.

As part of the ongoing review, Zevra received notification from the FDA that it required more time to review the additional analyses provided by the Company in responses to recent information requests generated from the FDA's review.

Тэгов: ZVRA
read more
Zevra Therapeutics Resubmits Arimoclomol NDA To FDA

Zevra Therapeutics Resubmits Arimoclomol NDA To FDA

Zevra Therapeutics, Inc. (ZVRA) announced Wednesday it resubmitted its New Drug Application (NDA) for arimoclomol to the U.S. Food and Drug Administration (FDA) on December 22, 2023. Arimoclomol is an investigational therapeutic candidate for the treatment of Niemann-Pick disease type C (NPC).
RTTNews | 579 дней спустя
Euro Falls Against Majors

Euro Falls Against Majors

The euro weakened against other major currencies in the pre-European session on Tuesday.
RTTNews | 24 минут назад
European Economic News Preview: UK Mortgage Approvals Data Due

European Economic News Preview: UK Mortgage Approvals Data Due

Mortgage approvals from the UK and flash GDP from Spain are the top economic news due on Tuesday. At 3.00 am ET, Spain's statistical office INE publishes flash GDP data and retail sales figures. The economy is forecast to grow at a steady pace of 0.6 percent in the second quarter.
RTTNews | 1ч 1мин назад
Australian Market Trims Early Losses In Mid-market

Australian Market Trims Early Losses In Mid-market

The Australian stock market is trimming is early losses in mid-market trading on Tuesday, reversing the slight gains in the previous session, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying well below the 8,700 level, with weakness in financial and technology stocks partially offset by some gains in energy stocks.
RTTNews | 3ч 32мин назад
Asian Markets Trade Mostly Lower

Asian Markets Trade Mostly Lower

Asian stock markets are trading mostly lower on Tuesday, following the mixed cues from Wall Street overnight, as traders remain cautious ahead of the U.S. interest rate decision later in the week and as they await the outcome of the U.S.-China trade talks. Meanwhile, several European leaders voiced concerns over the EU-U.S. trade deal, calling it 'lopsided' and 'unsustainable'.
RTTNews | 3ч 39мин назад